News from actinium pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 08, 2014, 09:40 ET

With Bone Marrow Transplants Rising, New Therapy Gives Hope to Those Over 55

 Bone marrow transplants are a $1.3 billion market and the fastest-growing hospital procedure in the U.S. They are the only potential cure for...

Dec 20, 2013, 08:35 ET

Four Things to Ask Your Doctor About Bone Marrow Transplants

Those who have leukemia, lymphoma or other blood cancer diseases might have heard about bone marrow transplant as a potential treatment. As with...

Dec 09, 2013, 16:05 ET

Actinium Pharmaceuticals to Present at the 24th Annual Oppenheimer Healthcare Conference

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative targeted...

Dec 09, 2013, 07:00 ET

Actinium Pharmaceuticals Announces Clinical Advisory Board Meeting At The 2013 ASH Conference

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...

Dec 09, 2013, 06:00 ET

Encouraging Clinical Data From Multicenter Phase 1/2 Trial On Actinium's Actimab-A Presented At American Society Of Hematology Annual Meeting

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted...

Dec 05, 2013, 07:00 ET

Actinium Pharmaceuticals Presenting At The LD Micro Conference Today At 12:30 pm Pacific

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...

Dec 03, 2013, 07:00 ET

Actinium Pharmaceutical's Announces Analyst Coverage

BURTON, Mich., Dec. 3, 2013 /PRNewswire/-- Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) a pharmaceutical company developing drugs for...

Dec 03, 2013, 07:00 ET

Actinium Pharmaceuticals Announces 2013 Annual Shareholder Meeting

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...

Dec 02, 2013, 07:00 ET

Actinium Pharmaceuticals Announces Additional Clinical Data From Multicenter Phase 1/2 Trial on Actinium's Actimab-A to Be Presented at American Society of Hematology Annual Meeting

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...

Nov 21, 2013, 07:00 ET

Actinium Pharmaceuticals To Present At The LD Micro Conference

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted...

Nov 18, 2013, 07:00 ET

Actinium Pharmaceuticals Announces Plans For Iomab™-B Phase 3 Pivotal Trial Following Meeting With FDA

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative, targeted...

Nov 12, 2013, 07:00 ET

Actinium Pharmaceuticals Appoints Richard Steinhart As New Independent Director

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative targeted...

Nov 08, 2013, 07:00 ET

Actinium Pharmaceuticals To Host Corporate Update And Virtual Roadshow Conference Call On November 11

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative targeted...

Oct 31, 2013, 06:30 ET

Actinium Pharmaceuticals to Host Corporate Update and Virtual Roadshow Conference Call on November 11

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative targeted...

Oct 15, 2013, 07:00 ET

Actinium Pharmaceuticals Webinar To Discuss Iomab™-B At 11AM EDT Today

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative...

Oct 03, 2013, 16:04 ET

Actinium Pharmaceuticals Announces Upcoming Webinar To Discuss Iomab™-B

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative...

Sep 18, 2013, 06:00 ET

Actinium Pharmaceuticals Appoints Corey Sohmer As Vice President Of Finance And Business Development

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative...

Sep 16, 2013, 06:00 ET

Actinium Pharmaceuticals Appoints Kaushik J. Dave, Ph.D., MBA As President, Chief Executive Officer And Director

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative...

Jul 09, 2013, 07:00 ET

Actinium Pharmaceuticals Clinical Results Featured at a United Nations Forum

 Actinium Pharmaceuticals Inc. (OTCQB: ATNM), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics for...

Jun 07, 2013, 07:00 ET

Actinium Pharmaceuticals, Inc. Receives $3.5m from Exercise of Warrants

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) announced today the recent issuance of 2,095,204 of its shares of common stock pursuant to the...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge